Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/ leucovorin in advanced pancreatic adenocarcinoma
- 1 April 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (4) , 696-697
- https://doi.org/10.1016/s0959-8049(96)00438-8
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- Pancreatic carcinomaAnnals of Oncology, 1995
- High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot studyEuropean Journal Of Cancer, 1993
- Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaAnnals of Oncology, 1993